NCT02765399View on ClinicalTrials.gov

The Effect of Liraglutide Treatment on Postprandial Chylomicron and VLDL Kinetics, Liver Fat and de Novo Lipogenesis

PHASE4CompletedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

February 1, 2015

Primary Completion Date

February 28, 2019

Study Completion Date

February 28, 2019

Conditions
Type 2 Diabetes
Interventions
DRUG

Liraglutide

DRUG

Placebo

Trial Locations (1)

00029

Helsinki University Central Hospital, Helsinki

All Listed Sponsors
collaborator

Göteborg University

OTHER

lead

Helsinki University Central Hospital

OTHER

NCT02765399 - The Effect of Liraglutide Treatment on Postprandial Chylomicron and VLDL Kinetics, Liver Fat and de Novo Lipogenesis | Biotech Hunter | Biotech Hunter